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Abstract
Invasive Non-typhoidal Salmonella (iNTS) disease is a major public health challenge, espe-
cially in Sub-Saharan Africa (SSA). In Kenya, mortality rates are high (20–25%) unless
prompt treatment is instituted. The most common serotypes are Salmonella enterica sero-
type Typhimurium (S. Typhimurium) and Salmonella enterica serotype Enteritidis (S. Enteri-
tidis). In a 5 year case-control study in children residing in the Mukuru informal settlement in
Nairobi, Kenya, a total of 4201 blood cultures from suspected iNTS cases and 6326 fecal
samples from age-matched controls were studied. From the laboratory cultures we obtained
a total of 133 S. Typhimurium isolates of which 83(62.4%) came from cases (53 blood and
30 fecal) and 50(37.6%) from controls (fecal). A total of 120 S. Enteritidis consisted of 70
(58.3%) from cases (43 blood and 27 fecal) and 50(41.7%) from controls (fecal).
The S. Typhimurium population fell into two distinct ST19 lineages constituting 36.1%, as
well as ST313 lineage I (27.8%) and ST313 lineage II (36.1%) isolates. The S. Enteritidis
isolates fell into the global epidemic lineage (46.6%), the Central/Eastern African lineage
(30.5%), a novel Kenyan-specific lineage (12.2%) and a phylogenetically outlier lineage
(10.7%). Detailed phylogenetic analysis revealed a high level of relatedness between NTS
from blood and stool originating from cases and controls, indicating a common source pool.
Multidrug resistance was common throughout, with 8.5% of such isolates resistant to
extended spectrum beta lactams. The high rate of asymptomatic carriage in the population
is a concern for transmission to vulnerable individuals and this group could be targeted for
vaccination if an iNTS vaccine becomes available.
PLOS NEGLECTED TROPICAL DISEASES
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0008440 August 3, 2020 1 / 14
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPEN ACCESS
Citation: Kariuki S, Mbae C, Van Puyvelde S,
Onsare R, Kavai S, Wairimu C, et al. (2020) High
relatedness of invasive multi-drug resistant non-
typhoidal Salmonella genotypes among patients
and asymptomatic carriers in endemic informal
settlements in Kenya. PLoS Negl Trop Dis 14(8):
e0008440. https://doi.org/10.1371/journal.
pntd.0008440
Editor: Abiola Senok, Mohammed Bin Rashid
University of Medicine and Health Sciences,
UNITED ARAB EMIRATES
Received: January 7, 2020
Accepted: June 2, 2020
Published: August 3, 2020
Copyright: © 2020 Kariuki et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the manuscript and its Supporting
Information files.
Funding: Research reported in this publication was
supported by the National Institute of Allergy and
Infectious Diseases of the National Institutes of
Health under Award Number R01AI099525 to S.K.
and the Wellcome Trust. GD was supported by
Author summary
Blood-stream infections in young children in Sub-Saharan Africa cause high levels of
morbidity and mortality. Non-typhoidal Salmonella (NTS) serovars Typhimurium and
Enteritidis are especially important in causing blood-stream infections in Kenya. In this
case-control study we examined a total of 4201 children with potential blood-stream
infections and compared their NTS genotypes with those found in fecal samples of 6326
asymptomatic age-matched controls. From a phylogenetic analysis, we observed a high
rate of carriage in cases and controls of multidrug resistant Salmonella genotypes with
similarity to those causing invasive disease. We hypothesize that the high carriage rates in
asymptomatic population may be contributing to maintenance and transmission of NTS
disease among vulnerable population of children.
Introduction
Non-typhoidal Salmonella (NTS) disease is responsible for an estimated 3.4 million global
cases annually, where it is predominantly associated with gastroenteritis. In most parts of the
world NTS is not normally associated with invasive (bloodstream) disease. However, in Sub-
Saharan Africa (SSA) there is a high burden of this type of disease, particularly in infants, with
an untreated case fatality rate between 20 to 25% [1–5]. Among iNTS cases in SSA, it is esti-
mated that ~65% occur in children <5 years of age [1], with a range from 166-568/100,000
cases of person-years of observation (pyo). iNTS disease in SSA is more prevalent amongst
Human Immunodeficiency Virus (HIV)-infected individuals, infants, and young children
with malaria, anaemia and malnutrition [4].
Increasing antimicrobial resistance in iNTS is of great global concern where empiric oral
options for effective treatment of life-threatening invasive disease are being rapidly eroded.
Multi-drug resistance (MDR) (resistance to first line drugs such as ampicillin, sulpha-trimeth-
oprim and chloramphenicol) in iNTS has been reported in Kenya and Malawi [6–8], and in
other parts of SSA [9–11]. MDR Salmonella serotype Typhimurium of a novel sequence type
(ST) 313 is endemic in SSA countries including Kenya [8], Malawi [6], the DRC [12], Nigeria
[13], Ghana [14], South Africa [15] and Mozambique [16]. In these settingsST313 frequently
produces septicemia in the absence of gastroenteritis. Recently we reported on the emergence
of MDR ST 313 also resistant to extended spectrum beta lactams (ESBL) (including ceftriax-
one) encoded on a CTX-M-15 gene located on a 304kb plasmid. Ceftriaxone is among the last-
line antimicrobials used to treat severe life-threatening bacterial infection in our setting. iNTS
isolates with resistance to ceftriaxone have also been reported in other countries in SSA: the
Democratic Republic of the Congo (DRC) [12, 17], Malawi [18, 19] and South Africa [20].
MDR S. Enteriditis ST11, has also emerged in Kenya [21, 22] and Malawi [7], while in Ghana
we have recent reports of emergence of fluoroquinolone resistance strains [23]. However,
ESBL producing strains have not been reported.
While zoonotic animal reservoirs of iNTS ST313 remain unclear, it is hypothesized that
iNTS infections can be transmitted through human-to-human contacts [22, 24]. Household
asymptomatic carriers are thought to be a major reservoir and source for spread of infection to
vulnerable individuals. Nairobi, Kenya’s largest urban centre, has an estimated population of
4.5 million, a third of who live in informal settlements that lack proper sanitary and clean
water facilities. The dense population and sub-optimal hygiene and sanitation contribute to
the high burden of diseases due to enteric pathogens in these settings. Here, we report on
MDR iNTS from patients treated at outpatient clinics that have a high degree of phylogenetic
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relatedness to strains isolated from asymptomatic carriers; indicating possible human-human
transmission in the community settings.
Materials and Methods
Study site
Mukuru informal settlement is situated in the eastern side of Nairobi about 15 KM from the city
centre. It is one of the largest slums in the city with a population of around 250,000 people [25].
Informal settlements are made up of improvised temporary dwellings often made from scrap mate-
rials, such as corrugated metal sheets, plywood, and polythene-sheets. The informal settlements are
densely populated and characterized by limited basic services and infrastructure for providing clean
water, sanitation facilities, solid-waste management, roads, drainage, and electricity [26]. In addition
to poverty, a number of factors associated informal settlements, including overcrowding, substan-
dard housing, unclean and insufficient quantities of water, and inadequate sanitation, contribute to
a high incidence of infectious diseases and increased mortality among those under five years [27,
28]. Mukuru Informal settlement is divided into eight villages; Mukuru Lunga-Lunga, Mukuru kwa
Sinai, Mukuru kwa Reuben, Mukuru kwa Njenga, Mukuru Kayaba and Mukuru North. The two
major villages within the larger Mukuru, Mukuru kwa Njenga and Mukuru kwa Reuben, were
mapped. This was done through digitizing detailed physical structures, creation of geographic data
of road networks and projection of geographic data in a plane using Universal Transverse Mercator
system. Mukuru Reuben was demarcated into 9 zones with 7037 blocks, while Mukuru kwa Njenga
had 8 zones with 8059 blocks (Fig 1). In total, 32,000 households were mapped.
Study subjects and specimen collection
The study population residing in Mukuru informal settlment receive routine immunization for
common diseases within the Expanded programme on immunization. Patients presenting for
care at 4 outpatient medical facilities that serve the informal settlement were approached for par-
ticipation in the study if they were<16 years of age on the date of presentation; resided in the
Mukuru slum; presented with a subjective history of at least 3 days of fever and have an axillary
temperature of at least 37.5 oC or they presented with a history of fever of any duration and have
an axillary temperature of at least 37.5˚C; or they reported having had three or more loose or liq-
uid stools (children> 2 years) or 8 or more for infants in the 24 hours before presentation, or
one or more loose or liquid stool with visible blood. Eligible patients whose guardians gave writ-
ten informed consent had a detailed history and physical examination recorded on a structured
data form and a blood and stool specimen taken for culture. A structured questionnaire (S1
Table) was used to elucidate the following information from each case after blood and stool (or
rectal swabs for those that stool samples were unavailable) samples were collected: clinical mani-
festations (e.g. vomiting, fever, and/or dehydration), demographic data (age, sex, and residence),
and types of stool samples (watery, mucous, or bloody, or other form). Controls recruited for the
study were age-matched children who came to the health facility for well mother and child clinic
including routine vaccinations. Whenever available, two age-matched controls were randomly
selected for each case identified. A questionnaire was used to obtain medical history of the con-
trol, and their demographic data (age, sex, and residence). From each control, a stool or rectal
swab were obtained and recorded as formed, watery, mucous, bloody, or other form.
Detection of bacterial pathogens
Blood for culture. For blood culture 1–3 ml for children < 5 years of age and 5–10 ml for
5–16 years of age was collected in syringe, placed into culture media in Bactec bottles, and
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transported daily to and analyzed at the KEMRI laboratory. Blood cultures were incubated at
37˚C in a computerized BACTEC 9050 Blood Culture System (BD, Franklin Lakes, New Jer-
sey, USA), and subcultured after 24 h onto blood, chocolate and MacConkey agar plates. The
blood cultures were subsequently observed for a further 7 days for signs of bacterial growth
Fig 1. Mapped villages constituting Mukuru informal settlement study site. The image was acquired from Google Earth to create the
map of structures/buildings of the study area as the first step of creating the GIS database. The images were geometrically rectified to a
known coordinate system (Universal Transverse Mercator (UTM) 37S on the basis of a number of Ground Control Points (GCPs),
selected from the periphery of the study area so that possible errors would converge towards middle of the area. Images were converted
into TIFF files in ArcGIS10x software.
https://doi.org/10.1371/journal.pntd.0008440.g001
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(auto-detection). A final subculture was performed for all blood cultures on the 8th day
regardless of the state of bacterial growth. From the subcultures, bacterial isolates were identi-
fied using biochemical tests on API20E strips (API System, Montalieu Vercieu, France) and
further typed by species-specific serological tests.
HIV serology/PCR tests. Comprehensive testing for HIV for all children whose HIV sta-
tus is not known is currently routine in each of the clinical study sites. After providing counsel-
ling by qualified HIV counsellors and informed consent from parents or guardians (and assent
for children 7 years of age and older), a drop of blood was spotted onto Whatman absorbent
filter paper (Schleicher & Schuell 903 or Whatman BFC 180). The samples were transported to
KEMRI laboratory for testing. Children above 18 months of age were tested using the Deter-
mine HIV Rapid test and confirmed using the Uni-Gold Rapid HIV test kits. These are the kits
approved by Ministry of Health. For children below 18 months of age, HIV status was evalu-
ated by PCR. Any HIV seropositive children were referred to a clinic physician for further
evaluation and management.
Malaria blood smear test. As malaria is a major differential diagnosis in children present-
ing with fever, a malaria smear (thick and thin) was made for all cases. The smear slides were
Giemsa stained and read on-site. Results were entered into study cards and also given to the
clinician for patient management.
Stool cultures. The rectal swab or loopful of the stool specimen was transported to
KEMRI laboratory and initially cultured on selenite F (Oxoid, Basingstoke, UK) broth aerobi-
cally at 37˚C overnight. Broth cultures were then subcultured on MacConkey agar and Salmo-
nella-Shigella agar (Oxoid) and incubated at 37˚C overnight. To identify suspect Salmonella
bacteria, non-lactose fermenting colonies were biochemically tested using triple sugar iron
(TSI) slants. From the subcultures, bacterial isolates were identified using biochemical tests on
API20E strips and further typed by species-specific serological tests.
Antibiotic susceptibility testing. Antibiotic susceptibility testing was performed using
the disk diffusion technique for all commonly used antimicrobials in Kenya on Mueller-Hin-
ton agar (Oxoid, Basingstoke, UK). For Gram negative enteric bacterial spp this includes ampi-
cillin 10μg, tetracycline 30μg, gentamicin 10μg, trimethoprim 5μg, sulphamethoxazole 100μg,
chloramphenicol 30μg, co-amoxiclav 20:10μg, cefuroxime 30μg, ceftazidime 30μg, ceftriaxone
30μg, cefotaxime 30μg, ciprofloxacin 5μg and nalidixic acid 10μg. MICs were performed using
the E-test strips (AB BIODISK, Solna, Sweden). Results were interpreted according to the
guidelines provided by the Clinical and Laboratory Standards Institute, 2017 [29].
Genomic analysis of NTS isolates. Genomic DNA from the NTS isolates listed in S2
Table was extracted using the Wizard Genomic DNA Extraction Kit (Promega, Wisconsin,
USA). Two μg of genomic DNA was subjected to whole genome sequencing (WGS) using Illu-
mina sequencing for high resolution and high throughput sample analysis. Sequence data is
made publicly available and accession numbers are included in S2 Table. Quality was checked
through assembly and mapping statistics, and Kraken output was used to check for contamina-
tion. Genomics MLST was determined using the SRST2 software. S. Typhimurium sequences
were mapped to S. Typhimurium D23580 (Accession Number = NC_016854), S. Enteritidis
sequences to S. Enteritidis P125109 (Accession Number = NC_011294.1) using SMALT v0.7.4.
Variation detection was performed using samtools mpileup v0.1.19 with parameters “-d 1000
-DSugBf” and bcftools v0.1.19 [30]. A pseudo-genome was constructed by substituting the
base call at each site (variant and non-variant) in the BCF file into the reference genome and
any site called as uncertain was substituted with an N. Insertions with respect to the reference
genome were ignored and deletions with respect to the reference genome were filled with N’s
in the pseudo-genome to keep it aligned and the same length as the reference genome used for
read mapping. Plasmids and recombinant regions (prophages and CRISPR sequences) in the
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chromosome were removed from the alignment. SNP sites were extracted from the alignment
using snp-sites [31] and used to construct a maximum likelihood phylogeny. RAxML v8.2.8
[32] with substitution model GTRCAT. Support for nodes on the trees was assessed using 100
bootstrap replicates. The S. Typhimurium strains and S. Enteritidis stains were aligned to ref-
erence genomes Salmonella Typhimurium D23580 and S. Enteritidis P125109, respectively,
using a pipeline developed in-house at the Wellcome Trust Sanger Institute (WTSI). Trees
were visualized using iTOL [33]. To identify the lineages, the sequences from this study were
phylogenetically analysed within the African context of Feasey et al. and Van Puyvelde et al.,
[7, 34]. Resistance genes were determined from the raw Illumina sequencing data using ariba v
2.12.1 [35] with CARD database version 3.0.2 [36].
Ethical Considerations. The study was approved by the Scientific and Ethics Review Unit
(SERU) of KEMRI (SSC No. 2076). All parents and/or guardians of participating children
were informed of the study objectives and voluntary written consent was sought and obtained
before inclusion. A copy of the signed consent was filed and stored in password protected cabi-
nets at KEMRI.
Hypothesis. The hypothesis was that high carriage rates of NTS strains in non-symptom-
atic individuals in the community may facilitate human-to-human NTS transmission.
Results
Patients and controls
From the 4 health facilities, a total of 10,527 children were recruited into the study; 4,201 were
cases and 6,326 were healthy controls. In the study, a total of 4201 blood cultures from suspect
iNTS cases and stool samples from 6326 age-matched controls were obtained from children
less than 5 years of age. The majority of the suspect iNTS cases (26.1%) were aged 13–24
months, with the number decreasing to 14.1% in the age group 49–60 months Table 1). 1.3%
of the children were reported to be HIV positive, 4.1% tested malaria positive.
Highly related case and control isolates form a diverse NTS population
From the 4201 blood cultures from cases and 6326 fecal samples from age-matched controls
we obtained a total of 133 S. Typhimurium isolates of which 83(62.4%) came from cases (53
blood and 30 fecal) and 50(37.6%) from controls (fecal). A total of 120 S. Enteritidis consisted
of 70(58.3%) from cases (43 blood and 27 fecal) and 50(41.7%) from controls (fecal). Whole
genome sequencing and phylogenetic analysis showed that both the invasive and enteric S.
Typhimurium (133 isolates) and S. Enteritidis (120 isolates) form two distinct bacterial popu-
lations with different substructures (Figs 2 and 3), but with minimal phylogenetic differences
between invasive and enteric isolates. The S. Typhimurium isolates harbour 4389 and the S.
Enteritidis isolates 3175 core SNPs difference.
Table 1. Age distribution of patients, both cases and controls.
Case Control
Age category No. (%) No. (%)
0–12 months 811 (19.3) 846 (13.4)
13–24 months 1096 (26.1) 1812 (28.6)
25–36 months 875 (20.8) 1412 (22.3)
37–48 months 828 (19.7) 1304 (20.6)
49–60 months 591 (14.1) 952 (15.1)
Total 4201 (100) 6326 (100)
https://doi.org/10.1371/journal.pntd.0008440.t001
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Whereas the current pandemic of invasive S. Typhimurium isolates across SSA is domi-
nated by ST313 lineage II isolates, the Kenyan S. Typhimurium population is more diverse and
falls into four lineages; two ST19 lineages (36.1%), ST313 lineage I (27.8%) and ST313 lineage
II (36.1%) (Fig 2 and S1 Fig).
The S. Enteritidis isolates fell into four different lineages; the global epidemic lineage
(46.6%), a so called outlier lineage (10.7%), a Central/Eastern African lineage (30.5%) as
defined by Feasey et al. (2016) [7], and a novel Kenyan lineage (12.2%) (Fig 3 and S2 Fig).
In all S. Typhimurium and S. Enteritidis lineages, the isolates from blood and stool, origi-
nating from cases and controls were randomly distributed across the phylogenetic tree. In
addition, in 8 cases the serotypes isolated from blood and from stool samples from the same
individual were different (S. Enteritidis and S. Typhi, 4; S. Typhimurium and S. Typhi, 2; S.
Typhimurium and S. Enteritidis, 2). However, corresponding isolates from individual cases
and controls showed high genetic relatedness, with some examples where identical genotypes
(0 core genome SNPs difference) were found among cases and controls.
NTS lineages have heterogeneous distributions of antimicrobial resistance
genes
A total of 150/253(59.3%) NTS were resistant to 2 or more commonly available antimicrobials.
The most common resistance phenotype were resistance to ampicillin, chloramphenicol, and
sulphamethoxazole-trimethoprim (70%). In addition, 23(9.1%) isolates were resistant to
extended spectrum beta lactams (cefotaxime or ceftriaxone or ceftazidime), and one isolate
was resistant to ciprofloxacin. Using the Yates chi-square test there was no significant relation-
ship between MDR phenotype with either age, co-morbidity with malaria, sickle cell trait or
HIV status.
The presence of AMR genetic markers was correlated with specific phylogenetic clades,
irrespective of the source of the isolate (case or control). Isolates that fell in S. Typhimurium
ST313 lineages I and II and the Central/Eastern S. Enteritidis lineage show the highest AMR
levels, with high abundance of MDR resistance genes and presence of ESBL genes (Figs 2 and
3). The majority of isolates that fell in S. Typhimurium ST19 lineages I and II (30/39; 77.0%)
and the S. Enteritidis global epidemic lineage (44/54; 81.5%), did not harbor common genetic
markers for AMR. Resistance genes contributing to the MDR phenotype (blaTEM, dfrA, sul
and cat) were present in 52(39%) S. Typhimurium isolates and 3(2.5%) S. Enteritidis isolates.
A total of 36(27.1%) S. Typhimurium carried ESBL genes (blaCTX-M and blaOXA-1). SNPs
associated with decreased susceptibility to ciprofloxacin was identified in 3 S. Typhimurium
isolates (GyrA D87Y, n = 2 and GyrB S463A, n = 1) and 3 S. Enteritidis isolates (GyrA D87Y,
n = 2 and GyrA T83I, n = 1). Of note, one S. Typhimurium isolate showed resistance markers
for MDR, ESBL activity and a ciprofloxacin resistance marker, the hallmarks of an extensively
drug resistant (XDR) strain.
Prevalence of HIV and malaria in the study population
The prevalence of HIV was 2.4% among cases and 3.8% among controls, while that of malaria
was 4.1% among the cases and 1.8% among controls. Analysis for correlation of HIV and
malaria prevalence with presence of iNTS disease did not show any significant association.
Discussion
Invasive NTS disease in SSA continues to be a major cause of childhood morbidity and mortal-
ity [4, 6, 12, 22]. In Kenya the incidence ranges from 166-625/100,000 pyo, with mortality up
to 28% [22]. In our settings, we observed a prevalence of 4.3%, very similar to rates observed in
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Fig 2. Phylogenetic tree of S. Typhimurium isolates from this study. Maximum likelihood phylogenetic tree based on the 130 S. Typhimurium
genome sequences from this study. Sequencing reads were mapped to S. Typhimurium ST313 lineage II reference strain D23580, and S. Typhi
10040_15 was added as an outgroup to root the tree. The tree is based on 61161 chromosomal SNPs. Patient state (case/control) and the source
(blood/stool) is visualized as indicated in the legend. Presence of multidrug resistance markers (MDR; bla, dfrA, sul, cat), blaCTX-M/blaOXA
antimicrobial resistance markers and SNPs in gyr are annotated. Branch lengths represent numbers of SNPs as indicated in the scale bar.
https://doi.org/10.1371/journal.pntd.0008440.g002
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Malawi [6], Burkina Faso [37] and the DRC [12]. The Mukuru informal settlement is densely
populated, and with poor WaSH characteristics, which facilitate the transmission of enteric
infections, including iNTS strains, in this endemic setting.
Fig 3. Phylogenetic tree of S. Enteritidis isolates from this study. Maximum likelihood phylogenetic tree based on the 120 S. Enteritidis genome sequences from this
study. Sequencing reads were mapped against S. Enteritidis reference strain P125109, and S. Typhi 10040_15 was added as an outgroup to root the tree. The tree is based
on 60302 chromosomal SNPs. Patient state (case/control) and the source (blood/stool) is visualized as indicated in the legend. Presence of multidrug resistance markers
(MDR; bla, dfrA, sul, cat) and SNPs in gyr are annotated. Branch lengths represent numbers of SNPs as indicated in the scale bar.
https://doi.org/10.1371/journal.pntd.0008440.g003
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The two main invasive S. enterica serotypes were S. Typhimurium (52.5%) and S. Enteritidis
(47.5%). Similar patterns of serotypes causing iNTS disease in SSA have been described previ-
ously in Malawi [6], Ghana [14], the DRC [17, 38] Mozambique [39] and Burkina Faso [37].
From the analysis of genomic data, the population of S. Typhimurium is moderately diverse,
with ST313 lineage I and ST313 lineage II being most common (63.9%), and ST19 lineages at
36.1%. In addition in 8 cases the serotypes isolated from blood and from stool samples of chil-
dren were different (S. Enteritidis and S. Typhi, 4; S. Typhimurium and S. Typhi, 2; S. Typhi-
murium and S. Enteritidis, 2). This clearly indicates the unique multiplicity of Salmonella
serotypes causing invasive disease in this population. Other studies in SSA [37, 39, 40] also
observed similar proportions for ST313 lineages I and II, but fewer ST19 strains. In Kenya it
appears that ST19 is also an important cause of iNTS disease as well asymptomatic carriage.
ST19 has also been described in other studies on iNTS SSA but at lower prevalence rates [4, 16,
41].
The population structure of S. Enteritidis was also diverse, with the most common lineages
(The East and Central Africa and the Global lineages), also being commonly found in other
SSA iNTS endemic countries [37, 42]. However, we observed a novel Kenyan lineage S. Enteri-
ditis (12.2%). The diverse population structure of both S. Typhimurium and S. Enteritidis that
form the main iNTS strains causing disease in Kenya could have implications for vaccine
development and coverage for candidate vaccines currently under development.
In this case-control study, analysis of proportions by the Yates chi-square test showed a
high correlation (p-value <0.01) between S. Typhimurium and S. Enteritidis genotypes in
cases and controls. This implies a potentially important role for asymptomatic carriage in the
community and this silent carriage could serve as possible source of infection for vulnerable
individuals. In addition, these findings further indicate a possible role for human-human
transmission as an important route for spread of iNTS disease in these endemic settings [24].
It will be crucial to understand the dynamics of transmission in these settings so we can target
the asymptomatic carriers for possible vaccination.
The S. Typhimurium and S. Enteritidis lineages previously linked to iNTS disease in Africa
including ST313 lineages I and II, and the Central/Eastern African Enteritidis lineage [42]
show the highest rates of antimicrobial resistance. In agreement with these previous observa-
tions, isolates from this study that fall in S. Typhimurium ST313 lineages I and II and the Cen-
tral/Eastern S. Enteritidis lineage show the highest antimicrobial resistance levels, with high
abundance of MDR genes and presence of ESBL genes. The most common resistance genes
associated with MDR were blaTEM, dfrA, sul and cat. These MDR NTS lineages have previ-
ously been described for their importance in the SSA iNTS pandemic [40, 42]. These MDR
genes on plasmids are self-transferrable between species and may play a major role in the
spread of AMR in the enteric bacteria population. One isolate had co-resistance of ciprofloxa-
cin and ceftriaxone; these drugs are treatment options of last resort for severe iNTS disease.
These isolates bear the characteristics of Extremely Drug Resistant (XDR) phenotype as previ-
ously described [34, 41, 43].
In conclusion, we observed a high prevalence of NTS carriage in the study population,
which may provide a significant reservoir for transmission, and maintenance of invasive dis-
ease in the population. Multidrug resistance including increasing resistance to extended spec-
trum beta-lactams and reduced susceptibility to fluoroquinolones presents a huge challenge
for management of severe infections in this population. As we face the challenges of treating
MDR iNTS disease, it is important to note that alternative effective options for management of
iNTS disease are dwindling. Indeed other options are often unavailable or too expensive to be
affordable to patients attending the public healthcare facilities. Where new effective antimicro-
bials are lacking, developments in vaccines may offer hope for reducing the burden of iNTS in
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endemic settings in SSA. A bivalent efficacious vaccine, targeting Salmonella serovars Typhi-
murium and Enteritidis, would significantly lower the disease burden in high-risk populations
especially as asymptomatic carriage in the endemic settings is high.
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